Cargando…
A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran
Objective: The purpose of the present study was a survey of venous thromboembolism (VTE) prophylaxis in obstetrics patients in Iran. Materials and methods: A national, multicenter, non-interventional, prospective study was performed on 1000 women at 11 different parts of Iran. Primary outcome was to...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911145/ https://www.ncbi.nlm.nih.gov/pubmed/31850094 |
_version_ | 1783479215673311232 |
---|---|
author | Mokhtari, Majid Nasri, Khadijeh Tara, Fatemeh Zarean, Elahe Hantoushzadeh, Sedigheh Radmehr, Mehrnaz Kashanian, Maryam |
author_facet | Mokhtari, Majid Nasri, Khadijeh Tara, Fatemeh Zarean, Elahe Hantoushzadeh, Sedigheh Radmehr, Mehrnaz Kashanian, Maryam |
author_sort | Mokhtari, Majid |
collection | PubMed |
description | Objective: The purpose of the present study was a survey of venous thromboembolism (VTE) prophylaxis in obstetrics patients in Iran. Materials and methods: A national, multicenter, non-interventional, prospective study was performed on 1000 women at 11 different parts of Iran. Primary outcome was to assess the situation of VTE prophylaxis in pregnant and postpartum women and the secondary outcome was risk stratification in obstetrics patients and to evaluate the guideline adherence in physician’s practice of VTE prophylaxis. Results: 1,036 women entered the final analysis. The three main VTE risk factors before hospitalization were BMI > 30 kg/m2, history of oral contraceptive (OCP) use, and the age over 35.VTE risk factors upon enrollment were detected in 780 (75.28%) patients. 219 women (28.07%) were deemed eligible for drug prophylaxis, however, only 37 women (17%) received it. A total of 113 (10.9%) patients received VTE prophylaxis, of which 76 (67.25%) women had no clear indications. Concordance between theory and practice was detected with a Cohen’s Kappa coefficient to be 0.74 (p < 0.001), which fell within “good agreement”. Multivariate analysis for association between VTE prophylaxis and VTE risk factors showed that history of VTE [OR = 9.06 (CI 95% 1.16 – 70.8) p = 0.036] was the most frequent risk factor for receiving VTE prophylaxis followed by obesity (BMI > 30 Kg/m2); [OR = 3.74 (CI 95% 1.79 – 5.69), p = <0.001], multiple pregnancy [OR= 2.81 (CI 95% 1.70 – 4.64), p = < 0.001] and age > 35 years; [OR =1.09 (CI 95% 0.82 – 1.21), p = 0.026]. Varicose Veins [OR= 0.22 (CI 95% 0.56 – 0.87), p = 0.031], PROM / PPROM [OR= 0.33 (CI 95% 0.12 – 0.91), p = 0.032] and history of using OCP [OR= 0.36 (CI 95% 0.24 – 0.53), p = < 0.001] were the most missed risk factors for receiving VTE prophylaxis respectively. Conclusion: History of VTE, obesity, multiple pregnancy and age > 35 years were the most frequent risk factors for receiving VTE prophylaxis and varicose veins, PROM / PPROM and history of using OCP were the most missed risk factors for receiving VTE prophylaxis. |
format | Online Article Text |
id | pubmed-6911145 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Tehran University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-69111452019-12-17 A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran Mokhtari, Majid Nasri, Khadijeh Tara, Fatemeh Zarean, Elahe Hantoushzadeh, Sedigheh Radmehr, Mehrnaz Kashanian, Maryam J Family Reprod Health Original Article Objective: The purpose of the present study was a survey of venous thromboembolism (VTE) prophylaxis in obstetrics patients in Iran. Materials and methods: A national, multicenter, non-interventional, prospective study was performed on 1000 women at 11 different parts of Iran. Primary outcome was to assess the situation of VTE prophylaxis in pregnant and postpartum women and the secondary outcome was risk stratification in obstetrics patients and to evaluate the guideline adherence in physician’s practice of VTE prophylaxis. Results: 1,036 women entered the final analysis. The three main VTE risk factors before hospitalization were BMI > 30 kg/m2, history of oral contraceptive (OCP) use, and the age over 35.VTE risk factors upon enrollment were detected in 780 (75.28%) patients. 219 women (28.07%) were deemed eligible for drug prophylaxis, however, only 37 women (17%) received it. A total of 113 (10.9%) patients received VTE prophylaxis, of which 76 (67.25%) women had no clear indications. Concordance between theory and practice was detected with a Cohen’s Kappa coefficient to be 0.74 (p < 0.001), which fell within “good agreement”. Multivariate analysis for association between VTE prophylaxis and VTE risk factors showed that history of VTE [OR = 9.06 (CI 95% 1.16 – 70.8) p = 0.036] was the most frequent risk factor for receiving VTE prophylaxis followed by obesity (BMI > 30 Kg/m2); [OR = 3.74 (CI 95% 1.79 – 5.69), p = <0.001], multiple pregnancy [OR= 2.81 (CI 95% 1.70 – 4.64), p = < 0.001] and age > 35 years; [OR =1.09 (CI 95% 0.82 – 1.21), p = 0.026]. Varicose Veins [OR= 0.22 (CI 95% 0.56 – 0.87), p = 0.031], PROM / PPROM [OR= 0.33 (CI 95% 0.12 – 0.91), p = 0.032] and history of using OCP [OR= 0.36 (CI 95% 0.24 – 0.53), p = < 0.001] were the most missed risk factors for receiving VTE prophylaxis respectively. Conclusion: History of VTE, obesity, multiple pregnancy and age > 35 years were the most frequent risk factors for receiving VTE prophylaxis and varicose veins, PROM / PPROM and history of using OCP were the most missed risk factors for receiving VTE prophylaxis. Tehran University of Medical Sciences 2019-03 /pmc/articles/PMC6911145/ /pubmed/31850094 Text en Copyright © Vali-e-Asr Reproductive Health Research Center, Tehran University of Medical Sciences This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Mokhtari, Majid Nasri, Khadijeh Tara, Fatemeh Zarean, Elahe Hantoushzadeh, Sedigheh Radmehr, Mehrnaz Kashanian, Maryam A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran |
title | A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran |
title_full | A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran |
title_fullStr | A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran |
title_full_unstemmed | A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran |
title_short | A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran |
title_sort | survey of venous thromboembolism (vte) prophylaxis in obstetrics patients in iran |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911145/ https://www.ncbi.nlm.nih.gov/pubmed/31850094 |
work_keys_str_mv | AT mokhtarimajid asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT nasrikhadijeh asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT tarafatemeh asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT zareanelahe asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT hantoushzadehsedigheh asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT radmehrmehrnaz asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT kashanianmaryam asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT mokhtarimajid surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT nasrikhadijeh surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT tarafatemeh surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT zareanelahe surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT hantoushzadehsedigheh surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT radmehrmehrnaz surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran AT kashanianmaryam surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran |